Access
This article is part of Nature's premium content.
Published online 4 September 2009 | 461, 157 (2009) | doi:10.1038/461157a
News
Ethics scrutiny needed for Chinese-European projects
Panel calls for joint advisory body to monitor research.
Biomedical research collaborations between Europe and China need greater ethical oversight to combat unregulated stem-cell therapies and prevent the exploitation of clinical-trial participants. That's the message from a group of bioethics experts who are part of the Chinese–European BIONET project, a partnership set up to examine scientific collaborations between the regions.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
